Rodrigo Sánchez-Bayona

11PUBLICATIONS
92CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 10, 2026
Special Issue "Breast Cancer: Molecular Pathology, Diagnosis, and Therapeutic Strategies".

Rodrigo Sanchez-Bayona

|Dec 03, 2025
Palbociclib, Trastuzumab, and Endocrine Therapy in Pretreated HER2-Positive and PAM50 Luminal Advanced Breast Cancer: Randomized Phase II, SOLTI-1303 PATRICIA Trial.

Eva Ciruelos, Tomás Pascual, Guillermo Villacampa

|Dec 01, 2025
Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer.

Esther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín-Aguilera

|Sep 10, 2025
A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer.

Luis Manso, Rodrigo Sánchez-Bayona, Juan Antonio Guerra

|Apr 25, 2025
HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab.

Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero

|Jan 17, 2025
Elacestrant in Women with Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer: Results from the Preoperative Window-of-Opportunity ELIPSE Trial.

Maria Vidal, Claudette Falato, Tomás Pascual

Pageof 2

Frequent Collaborators

4 joint publications

Aleix Prat

3 joint publications

Luis Manso

3 joint publications

Tomás Pascual

3 joint publications

Esther Sanfeliu